A Study to Test How Healthy Men Tolerate Different Doses of BI 1595043

Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 1595043 (Double-blind, Randomised, Placebo-controlled, Parallel Group Design) in Healthy Male Subjects

The primary objectives of this trial are to investigate safety and tolerability of BI 1595043 in healthy male subjects following administration of multiple rising doses over 14 days. Secondary objectives are the exploration of pharmacokinetics (PK) of BI 1595043 after single and multiple dosing.

A Study to Test How Healthy Men Tolerate Different Doses of BI 1595043

Recruitment

Summary

Participation Requirements

Description

Tracking Information